Nyxoah (NASDAQ:NYXH) & Zepp Health (NYSE:ZEPP) Financial Review

Zepp Health (NYSE:ZEPP) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Risk and Volatility

Zepp Health has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for Zepp Health and Nyxoah, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1	0	1	0	2.00
Nyxoah	1	0	3	0	2.50

Zepp Health presently has a consensus price target of $64.37, suggesting a potential upside of 129.56%. Nyxoah has a consensus price target of $12.67, suggesting a potential upside of 181.48%. Given Nyxoah’s stronger consensus rating and higher possible upside, analysts plainly believe Nyxoah is more favorable than Zepp Health.

Valuation & Earnings

This table compares Zepp Health and Nyxoah”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$182.60 million	2.23	-$75.73 million	($4.11)	-6.82
Nyxoah	$4.89 million	31.34	-$64.10 million	($2.49)	-1.81

Nyxoah has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Zepp Health and Nyxoah’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zepp Health	-28.28%	-21.45%	-9.20%
Nyxoah	-1,457.97%	-101.99%	-66.74%

Institutional and Insider Ownership

52.6% of Zepp Health shares are held by institutional investors. 36.0% of Zepp Health shares are held by insiders. Comparatively, 17.1% of Nyxoah shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Nyxoah beats Zepp Health on 8 of the 14 factors compared between the two stocks.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.